Login to Your Account

Earnings Roundup

Wednesday, December 14, 2011
• Avanir Pharmaceuticals Inc., of Aliso Viejo, Calif., reported fourth quarter financial results, including $4.3 million in gross revenues for Neudexta (dextromethorphan HBr and quinidine sulfate) and a cash burn of $14 million.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription